NYSE:TDOCHealthcare Services
How Teladoc’s Slower Revenue but Narrower Losses Will Impact Teladoc Health (TDOC) Investors
Teladoc Health, Inc. recently reported first-quarter 2026 results, with sales of US$613.85 million compared to US$629.37 million a year earlier and a net loss of US$63.84 million versus US$93.01 million previously, alongside basic and diluted loss per share from continuing operations of US$0.36 compared with US$0.53.
The combination of slightly lower revenue but a narrower loss suggests Teladoc is making some progress on cost control and efficiency even as top-line momentum softens.
With...